Patents by Inventor Joseph Tung

Joseph Tung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method on clinical applications in head neck cancer by using DSG3 molecule for predicting malignant degree of cancer, serving as a molecular target and using RNA jamming sequence on inhibition-specific of DSG3 expression
    Patent number: 7732594
    Abstract: The present invention provide a method for analyzing the DSG3 overexpression in tumor tissues with clinical features of cancer cells to validate that overexpression is relates to size, depth and migration of tumor. Therefore, DSG3 overexpression is capable for using in clinical applications, determining malignant degree of tumor, serving as molecular target in Head Neck Cancer (HNC). Moreover, a jamming sequence, RNA, is designed to act on DSG3 mRNA and is effective inhibition-specific DSG3 expression, and then inhibits cell growth, invasion and migration in HNC.
    Type: Grant
    Filed: March 17, 2009
    Date of Patent: June 8, 2010
    Assignees: Chang Gung University, Chang Gung Memorial Hospital
    Inventors: Joseph Tung-Chieh Chang, Ann-Joy Cheng, Yin-Ju Chen
  • Method on clinical applications in head neck cancer by using DSG3 molecule for predicting malignant degree of cancer, serving as a molecular target and using RNA jamming sequence on inhibition-specific of DSG3 expression
    Patent number: 7622456
    Abstract: The present invention provide a method for analyzing the DSG3 overexpression in tumor tissues with clinical features of cancer cells to validate that DSG3 overexpression is relates to size, depth and migration of tumor. Therefore, DSG3 overexpression is capable for using in clinical applications, determining malignant degree of tumor, serving as molecular target in Head Neck Cancer (HNC). Moreover, a jamming sequence, RNA, is designed to act on DSG3 mRNA and is effective inhibition-specific DSG3 expression, and then inhibits cell growth, invasion and migration in HNC.
    Type: Grant
    Filed: November 6, 2006
    Date of Patent: November 24, 2009
    Assignees: Non-Profit Organization Chang Gung Memorial Hospital, Chang Gung University
    Inventors: Joseph Tung-Chieh Chang, Ann-Joy Cheng, Yin-Ju Chen
  • Method on Clinical Applications in Head Neck Cancer by Using DSG3 Molecule for Predicting Malignant Degree of Cancer, Serving as a Molecular Target and Using RNA Jamming Sequence on Inhibition-Specific of DSG3 Expression
    Publication number: 20090233352
    Abstract: The present invention provide a method for analyzing the DSG3 overexpression in tumor tissues with clinical features of cancer cells to validate that overexpression is relates to size, depth and migration of tumor. Therefore, DSG3 overexpression is capable for using in clinical applications, determining malignant degree of tumor, serving as molecular target in Head Neck Cancer (HNC). Moreover, a jamming sequence, RNA, is designed to act on DSG3 mRNA and is effective inhibition-specific DSG3 expression, and then inhibits cell growth, invasion and migration in HNC.
    Type: Application
    Filed: March 17, 2009
    Publication date: September 17, 2009
    Applicants: CHANG GUNG UNIVERSITY, Non-Profit Organization Chang Gung Memorial Hospital
    Inventors: Joseph Tung-Chieh Chang, Ann-Joy Cheng, Yin-Ju Chen
  • Method on clinical applications in head neck cancer by using DSG3 molecule for predicting malignant degree of cancer, serving as a molecular target and using RNA jamming sequence on inhibition-specific of DSG3 expression
    Publication number: 20090029354
    Abstract: The present invention provide a method for analyzing the DSG3 overexpression in tumor tissues with clinical features of cancer cells to validate that DSG3 overexpression is relates to size, depth and migration of tumor. Therefore, DSG3 overexpression is capable for using in clinical applications, determining malignant degree of tumor, serving as molecular target in Head Neck Cancer (HNC). Moreover, a jamming sequence, RNA, is designed to act on DSG3 mRNA and is effective inhibition-specific DSG3 expression, and then inhibits cell growth, invasion and migration in HNC.
    Type: Application
    Filed: November 6, 2006
    Publication date: January 29, 2009
    Applicants: NON-PROFIT ORGANIZATION CHANG GUNG MEMORIAL HOSPITAL, CHANG GUNG UNIVERSITY
    Inventors: Joseph Tung-Chieh Chang, Ann-Joy Cheng, Yin-Ju Chen
  • Capturing intellectual capital via digital collaboration
    Publication number: 20020082998
    Abstract: A system and method are provided that allow users of a digital collaboration service to share information in such a way that an accurate record of the information shared during the digital collaboration is captured. Furthermore, the context in which the information is being exchanged amongst users of the service can also be captured. As a result, a system in accordance to one or more embodiments of the present invention is ideally suited for digital collaboration conducted amongst potential business partners, where maintaining an accurate record of what information was shared by each party is paramount. Furthermore, the capture of contextual information makes a system in accordance to one or more embodiments of the present invention ideally suited for digital collaboration conducted amongst users that are within the same company. For example, a development team may use a digital collaboration system in accordance to the present invention to conduct meetings.
    Type: Application
    Filed: September 25, 2001
    Publication date: June 27, 2002
    Inventors: Bharat Sastri, Charles Kuta, Joseph Tung
  • Chemical-mechanical polishing device
    Patent number: 6306022
    Abstract: A device for chemical-mechanical polishing. The device can be applied to a chemical polishing table spinning in a fixed direction and a polishing pad above of it. A chemical-mechanical polishing device according to the present invention is at least comprised of a main body of conditioner with a plurality of mounting pads, wherein each mounting pad is mounted with the diamond granules and located on the lower surface of conditioner, distributed on the rim of main body of each mounting pad. It can contact with polishing pads when cleaning the polishing pads and a number of cavities are across the upper and lower surfaces of each main body of conditioner and distributed between each mounting pads as well. When using the conditioners to clean out the polishing pads, the de-ionized water will flow through the cavities to wash off the acid or basic slurry to eliminate the destruction made by the solders around the diamond granules to extend the durability of the conditioner.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: October 23, 2001
    Assignees: Promos Technologies, Inc., Mosel Vitelic Inc., Infineon Technologies Inc.
    Inventors: Joseph Tung, Ming-Cheng Yang, Lung-Hu Lin, Jiun-Fang Wang